BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Biotime’s Additional Renevia Data From the Successful Pivotal Trial Was Presented at the IFATS Conference

  The Renevia data was presented by primary investigator Ramon Llull, MD, PhD, Director of Stem Europe Mallorca Center, Mallorca, Spain at the “Plenary Session 2 - Clinical Studies with SVF.”

  December 4, 2017

   · 

  4 min read
• Business

  Bioasis Implements Transition Plan for Its Board of Directors

  Bioasis announced that Rob Hutchison and Michael Hutchison have submitted their planned resignations from the board.

  December 4, 2017

   · 

  5 min read
• FDA

  Merz North America Announces New FDA Clearance for DESCRIBE PFD Patch

  The Patch, which is placed over tattoos prior to removal with a laser, allows physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session.

  December 4, 2017

   · 

  3 min read
• 

  Business

  Cutera Names a New CFO

  Ms. Gardiner has been serving in this role on a consulting basis since July 12, 2017.

  December 4, 2017

   · 

  2 min read
• Drug Development

  La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients With Beta Thalassemia

  LJ401-BT01 is a pivotal, multinational, multicenter, randomized, controlled study that is designed to enroll approximately 100 patients across 9 countries.

  December 4, 2017

   · 

  6 min read
• Business

  Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions

  As seasoned experts in discovering, developing and commercializing naturally derived technologies, MBI has created an industry leading platform of pest management and plant health products.

  December 4, 2017

   · 

  5 min read
• Drug Development

  Risankizumab Meets All Primary Endpoints Reporting Positive Results in it’s Fourth Pivotal Phase III Psoriasis Study

  Results from the first phase showed that after 16 weeks of treatment, risankizumab met the co-primary endpoints of at least a 90 percent improvement in the Psoriasis and Severity Index.

  December 4, 2017

   · 

  14 min read
• Business

  VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab

  HealthTab is a lab-accurate, point-of-care testing platform designed to support the expanding role of pharmacists while offering new potential sources of revenue and growth for pharmacy owners.

  December 4, 2017

   · 

  6 min read
• Atox Bio Closes $30M Investment

  The round was led by Arix Bioscience with participation from Adams Street Partners, Asahi Kasei and additional undisclosed investors.

  December 4, 2017

   · 

  3 min read
• Drug Development

  BeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in China

  This recognition is in conjunction with China’s 13th “five-year plan” in which the country continues to cultivate major products, solve vital problems and implement projects that achieve qualitative change in the world.

  December 4, 2017

   · 

  4 min read